Institutional Ownership
Estrella Immunopharma Inc
CUSIP 297584112*W EXP 09/29/202ESLAWQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).